IMMIX BIOPHARMA INC (IMMX) Forecast, Price Target & Analyst Ratings

NASDAQ:IMMX • US45258H1068

Current stock price

8.58 USD
+0.43 (+5.28%)
At close:
8.58 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMMIX BIOPHARMA INC (IMMX).

Forecast Snapshot

Consensus Price Target

Price Target
$16.66
+ 94.17% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.16
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$16.66
Upside
+ 94.17%
From current price of $8.58 to mean target of $16.66, Based on 8 analyst forecasts
Low
$12.12
Median
$14.28
High
$24.15

Price Target Revisions

1 Month
25.64%
3 Months
36.11%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for IMMX. The average price target is 16.66 USD. This implies a price increase of 94.17% is expected in the next year compared to the current price of 8.58.
The average price target has been revised upward by 36.11% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

IMMX Current Analyst RatingIMMX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

IMMX Historical Analyst RatingsIMMX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
IMMX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IMMX.
In the previous month the buy percentage consensus was at a similar level.
IMMX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-30MizuhoMaintains Outperform -> Outperform
2026-03-30HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-27CitizensReiterate Market Outperform -> Market Outperform
2026-03-27HC Wainwright & Co.Maintains Buy -> Buy
2026-03-25Morgan StanleyInitiate Overweight
2026-03-09CitizensInitiate Market Outperform
2026-02-09MizuhoInitiate Outperform
2025-12-09HC Wainwright & Co.Maintains Buy -> Buy
2025-09-12HC Wainwright & Co.Maintains Buy -> Buy
2025-06-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-06HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-03HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-19HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-26HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-09HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-01HC Wainwright & Co.Initiate Buy
2023-08-14Roth MKMReiterate Buy -> Buy
2023-02-22Roth MKMInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.16
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
0.55%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-7.59%
EPS (3 Months)
2.50%

Next Earnings Summary

IMMX is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.16 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
IMMX revenue by date.IMMX revenue by date.
N/AN/AN/AN/A
41.59%		N/A
147.59%		N/A
34.05%		N/A
49.35%		N/A
20.81%		N/A
6.30%
EBITDA
YoY % growth
IMMX ebitda by date.IMMX ebitda by date.
-840K-450K
46.43%		-1.35M
-200.00%		-8.22M
-508.89%		-16.136M
-96.30%		-22.642M
-40.32%		N/A
-16.12%		N/A
5.66%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IMMX ebit by date.IMMX ebit by date.
-840K-450K
46.43%		-1.35M
-200.00%		-8.22M
-508.89%		-16.141M
-96.36%		-22.675M
-40.48%		N/A
-20.45%		N/A
-38.07%		N/A
-53.98%		N/A
249.94%		N/A
-14.35%		N/A
67.99%		N/A
75.40%		N/A
28.22%		N/A
6.16%
Operating Margin
IMMX operating margin by date.IMMX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
IMMX eps by date.IMMX eps by date.
N/AN/AN/AN/A-0.88
-76.55%		N/A
14.46%		N/A
9.67%		N/A
26.00%		N/A
16.89%		N/A
765.85%		N/A
-62.27%		N/A
32.04%		N/A
63.24%		N/A
27.93%		N/A
7.39%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		-0.16
0.55%		-0.16
-7.78%		-0.17
20.49%		-0.19
20.95%		-0.22
-36.54%		-0.30
-87.38%		-0.40
-130.90%		-0.30
-56.99%		-0.34
-54.93%		-0.08
72.39%		-0.06
85.86%		0.03
111.64%
Revenue
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-7.58M
-51.98%		-8.227M
-75.69%		-8.442M
-25.66%		-9.594M
-25.21%		-11.052M
-45.81%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

IMMX Yearly Revenue VS EstimatesIMMX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
IMMX Yearly EPS VS EstimatesIMMX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
13.04%
EPS Next 5 Year
27.70%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
282.12%
Revenue Next 5 Year
187.26%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

IMMIX BIOPHARMA INC / IMMX Forecast FAQ

Can you provide the average price target for IMMIX BIOPHARMA INC stock?

8 analysts have analysed IMMX and the average price target is 16.66 USD. This implies a price increase of 94.17% is expected in the next year compared to the current price of 8.58.

When does IMMIX BIOPHARMA INC (IMMX) report earnings?

IMMIX BIOPHARMA INC (IMMX) will report earnings on 2026-05-06.

What are the consensus estimates for IMMIX BIOPHARMA INC (IMMX) next earnings?

The consensus EPS estimate for the next earnings of IMMIX BIOPHARMA INC (IMMX) is -0.16 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed IMMIX BIOPHARMA INC (IMMX)?

The number of analysts covering IMMIX BIOPHARMA INC (IMMX) is 8.